Načítá se...
Chromogranin A as a valid marker in oncology: Clinical application or false hopes?
Chromogranin A, due to its primary expression throughout the neuroendocrine system, is a widely accepted biomarker for the assessment of neuro-endocrine tumors. It has been traditionally used in the management of patients with tumors of gastro-enteropancreatic origin. Lately, it has also been implic...
Uloženo v:
| Vydáno v: | World J Methodol |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Baishideng Publishing Group Inc
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5366937/ https://ncbi.nlm.nih.gov/pubmed/28396845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5662/wjm.v7.i1.9 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|